The University of Chicago Header Logo

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer.

Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer. Ann Oncol. 2016 11; 27(11):2032-2038.

View in: PubMed